|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Watson PA, Arora VK and Sawyers CL:
Emerging mechanisms of resistance to androgen receptor inhibitors
in prostate cancer. Nat Rev Cancer. 15:701–711. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Coleman RE: Clinical features of
metastatic bone disease and risk of skeletal morbidity. Clin Cancer
Res. 12:6243s–6249s. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Edlind MP and Hsieh AC: PI3K-AKT-mTOR
signaling in prostate cancer progression and androgen deprivation
therapy resistance. Asian J Androl. 16:378–386. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
González-Alonso P, Cristóbal I, Manso R,
Madoz-Gúrpide J, García-Foncillas J and Rojo F: PP2A inhibition as
a novel therapeutic target in castration-resistant prostate cancer.
Tumor Biol. 36:5753–5755. 2015. View Article : Google Scholar
|
|
6
|
Bratt O and Schumacher MC: Natural history
of prostate cancer, chemoprevention and active surveillance. Acta
Oncol. 50(Suppl 1): S116–S119. 2011. View Article : Google Scholar
|
|
7
|
Dai Y, Qiao L, Chan KW, Yang M, Ye J, Ma
J, Zou B, Gu Q, Wang J, Pang R, et al: Peroxisome
proliferator-activated receptor-gamma contributes to the inhibitory
effects of Embelin on colon carcinogenesis. Cancer Res.
69:4776–4783. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zmijewski MA and Slominski AT:
Neuroendocrinology of the skin: An overview and selective analysis.
Dermatoendocrinol. 3:3–10. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim SW, Kim SM, Bae H, Nam D, Lee JH, Lee
SG, Shim BS, Kim SH, Ahn KS, Choi SH, et al: Embelin inhibits
growth and induces apoptosis through the suppression of
Akt/mTOR/S6K1 signaling cascades. Prostate. 73:296–305. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xie K: Interleukin-8 and human cancer
biology. Cytokine Growth Factor Rev. 12:375–391. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tanaka T, Bai Z, Srinoulprasert Y, Yang
BG, Hayasaka H and Miyasaka M: Chemokines in tumor progression and
metastasis. Cancer Sci. 96:317–322. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Waugh DJ and Wilson C: The interleukin-8
pathway in cancer. Clin Cancer Res. 14:6735–6741. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu J, Ren X, Chen Y, Liu P, Wei X, Li H,
Ying G, Chen K, Winkler H and Hao X: Dysfunctional activation of
neurotensin/IL-8 pathway in hepatocellular carcinoma is associated
with increased inflammatory response in microenvironment, more
epithelial mesenchymal transition in cancer and worse prognosis in
patients. PLoS One. 8:e560692013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li XJ, Peng LX, Shao JY, Lu WH, Zhang JX,
Chen S, Chen ZY, Xiang YQ, Bao YN, Zheng FJ, et al: As an
independent unfavorable prognostic factor, IL-8 promotes metastasis
of nasopharyngeal carcinoma through induction of
epithelial-mesenchymal transition and activation of AKT signaling.
Carcinogenesis. 33:1302–1309. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kido S, Kitadai Y, Hattori N, Haruma K,
Kido T, Ohta M, Tanaka S, Yoshihara M, Sumii K, Ohmoto Y and
Chayama K: Interleukin 8 and vascular endothelial growth
factor-prognostic factors in human gastric carcinomas? Eur J
Cancer. 37:1482–1487. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yuan A, Yang PC, Yu CJ, Chen WJ, Lin FY,
Kuo SH and Luh KT: Interleukin-8 messenger ribonucleic acid
expression correlates with tumor progression, tumor angiogenesis,
patient survival, and timing of relapse in non-small-cell lung
cancer. Am J Respir Crit Care Med. 162:1957–1963. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Araki S, Omori Y, Lyn D, Singh RK,
Meinbach DM, Sandman Y, Lokeshwar VB and Lokeshwar BL:
Interleukin-8 is a molecular determinant of androgen independence
and progression in prostate cancer. Cancer Res. 67:6854–6862. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kuai WX, Wang Q, Yang XZ, Zhao Y, Yu R and
Tang XJ: Interleukin-8 associates with adhesion, migration,
invasion and chemosensitivity of human gastric cancer cells. World
J Gastroenterol. 18:979–985. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li M, Zhang Y, Feurino LW, Wang H, Fisher
WE, Brunicardi FC, Chen C and Yao Q: Interleukin-8 increases
vascular endothelial growth factor and neuropilin expression and
stimulates ERK activation in human pancreatic cancer. Cancer Sci.
99:733–737. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shalapour S and Karin M: Immunity,
inflammation, and cancer: An eternal fight between good and evil. J
Clin Invest. 125:3347–3355. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Didonato JA, Mercurio F and Karin M: NF-κB
and the link between inflammation and cancer. Immunol Rev.
246:379–400. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
He G and Karin M: NF-κB and STAT3-key
players in liver inflammation and cancer. Cell Res. 21:159–168.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fan Y, Mao R and Yang J: NF-κB and STAT3
signaling pathways collaboratively link inflammation to cancer.
Protein Cell. 4:176–185. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Grivennikov SI and Karin M: Inflammation
and oncogenesis: A vicious connection. Curr Opin Genet Dev.
20:65–71. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Grivennikov SI and Karin M: Dangerous
liaisons: STAT3 and NF-kappaB collaboration and crosstalk in
cancer. Cytokine Growth Factor Rev. 21:11–19. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Terlizzi M, Casolaro V, Pinto A and
Sorrentino R: Inflammasome: Cancer's friend or foe? Pharmacol Ther.
143:24–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fang Y, Demarco VG and Nicholl MB:
Resveratrol enhances radiation sensitivity in prostate cancer by
inhibiting cell proliferation and promoting cell senescence and
apoptosis. Cancer Sci. 103:1090–1098. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fang Y, Herrick EJ and Nicholl MB: A
possible role for perforin and granzyme B in resveratrol-enhanced
radiosensitivity of prostate cancer. J Androl. 33:752–760. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fujita Y, Okamoto M, Goda H, Tano T,
Nakashiro K, Sugita A, Fujita T, Koido S, Homma S, Kawakami Y and
Hamakawa H: Prognostic significance of interleukin-8 and
CD163-positive cell-infiltration in tumor tissues in patients with
oral squamous cell carcinoma. PLoS One. 9:e1103782014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Punyani SR and Sathawane RS: Salivary
level of interleukin-8 in oral precancer and oral squamous cell
carcinoma. Clin Oral Investig. 17:517–524. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Herrero AB, Garcíagómez A, Garayoa M,
Corchete LA, Hernández JM, San Miguel J and Gutierrez NC: Effects
of IL-8 up-regulation on cell survival and osteoclastogenesis in
multiple myeloma. Am J Pathol. 186:2171–2182. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Perbellini O, Cioffi F, Malpeli G, Zanolin
E, Lovato O, Scarpa A, Pizzolo G and Scupoli MT: Up-regulation of
CXCL8/interleukin-8 production in response to CXCL12 in chronic
lymphocytic leukemia. Leuk Lymphoma. 56:1897–1900. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Brew R, Erikson JS, West DC, Kinsella AR,
Slavin J and Christmas SE: Interleukin-8 as a growth factor for
human colorectal carcinoma cells in vitro. Cytokine. 12:78–85.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Singh S, Singh AP, Sharma B, Owen LB and
Singh RK: CXCL8 and its cognate receptors in melanoma progression
and metastasis. Future Oncol. 6:111–116. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yao C, Lin Y, Chua MS, Ye CS, Bi J, Li W,
Zhu YF and Wang SM: Interleukin-8 modulates growth and invasiveness
of estrogen receptor-negative breast cancer cells. Int J Cancer.
121:1949–1957. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Singh RK and Lokeshwar BL: Depletion of
intrinsic expression of Interleukin-8 in prostate cancer cells
causes cell cycle arrest, spontaneous apoptosis and increases the
efficacy of chemotherapeutic drugs. Mol Cancer. 8:572009.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Karashima T, Sweeney P, Kamat A, Huang S,
Kim SJ, Bar-Eli M, McConkey DJ and Dinney CP: Nuclear factor-kappaB
mediates angiogenesis and metastasis of human bladder cancer
through the regulation of interleukin-8. Clin Cancer Res.
9:2786–2797. 2003.PubMed/NCBI
|
|
38
|
Kline M, Donovan K, Wellik L, Lust C, Jin
W, Moon-Tasson L, Xiong Y, Witzig TE, Kumar S, Rajkumar SV and Lust
JA: Cytokine and chemokine profiles in multiple myeloma;
significance of stromal interaction and correlation of IL-8
production with disease progression. Leuk Res. 31:591–598. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Karin M: Nuclear factor-kappaB in cancer
development and progression. Nature. 441:431–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shrimali D, Shanmugam MK, Kumar AP, Zhang
J, Tan BK, Ahn KS and Sethi G: Targeted abrogation of diverse
signal transduction cascades by emodin for the treatment of
inflammatory disorders and cancer. Cancer Lett. 341:139–149. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Profita M, Bonanno A, Siena L, Ferraro M,
Montalbano AM, Pompeo F, Riccobono L, Pieper MP and Gjomarkaj M:
Acetylcholine mediates the release of IL-8 in human bronchial
epithelial cells by a NFkB/ERK-dependent mechanism. Eur J
Pharmacol. 582:145–153. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nguyen DP, Li J, Yadav SS and Tewari AK:
Recent insights into NF-κB signalling pathways and the link between
inflammation and prostate cancer. BJU Int. 114:168–176. 2013.
View Article : Google Scholar
|
